William J. Chudd
Partner in our M&A group and co-head of our Private Equity practice. Broad-based practice spanning complex M&A, private equity and other matters.
Bill is a member of our Mergers & Acquisitions team and co-head of our interdisciplinary Private Equity practice. His diverse and broad-based practice encompasses both public and private M&A, private equity transactions, joint ventures, collaborations, restructurings, spinoffs and corporate governance matters.
He represents private equity firms and their portfolio companies in all aspects of their businesses, including acquisitions and dispositions of public and private companies, recapitalizations, minority investments, co-investment arrangements and sponsor team governance arrangements. His clients include Atairos, Bansk Group, Cerberus, Cornell Capital, Tailwind Capital and TruArc Partners.
He also represents multinational corporations on critical business initiatives and transactions, including both domestic and cross-border M&A. He has handled matters across multiple industries, with particular experience in the healthcare sector.
Experience highlights
Public Company and Take Private Transactions
- Shire’s:
- acquisition by Takeda, and proposed acquisition by AbbVie
- acquisitions of NPS Pharma and ViroPharma
- ExxonMobil acquisitions of InterOil and XTO Energy
- Comcast proposed acquisition of Time Warner Cable
- MSCI acquisition of RiskMetrics
- Maidenform acquisition by Hanesbrands
- Roche acquisition of Genentech
- VF acquisition of Timberland
- AstraZeneca acquisition of MedImmune
Healthcare and Life Sciences
- GSK acquisition of Affinivax
- Takeda disposition of Xiidra®
- Shire’s:
- acquisition by Takeda
- sale of Oncology business
- proposed acquisition by AbbVie
- acquisitions of NPS Pharma, ViroPharma, Foresight, Bikam, Lumena, SARcode, Lotus Tissue Repair, FerroKin and New River Pharmaceuticals
- Cornell Capital acquisitions of Fastaff, U.S. Nursing and trustaff
- Roche going-private acquisition of Genentech
- AstraZeneca acquisition of MedImmune
- Warner Chilcott global collaboration agreement with Sanofi-Aventis
- Ingenovis Health acquisition of Healthcare Support Staffing
Industrials and Energy
- EnVen Energy acquisition by Talos Energy
- ExxonMobil acquisitions of InterOil and XTO Energy
- Cornell Capital investments in MRC Global and Monolith Materials
- Tailwind Capital investments in Acertus, Anvil-Smith Cooper and Trench Plate Rental
Financial Services, Insurance and Investment Advice
- MSCI acquisitions of Burgiss, Insignis, IPD Group, Real Capital Analytics and RiskMetrics, and disposition of ISS
- FRBNY and the U.S. Treasury in the recapitalization of AIG
- PartnerRe acquisition of ParisRe
Tech, Media and Telecom
- Cerberus strategic investment in Comscore
- Atairos and NBCUniversal investment in Opry Entertainment Group
- Comcast proposed acquisition of Time Warner Cable
- Comcast investments in Clearwire Communication
Consumer Products and Retail
- Bansk Group acquisition of Woodstream and majority investments in amika and Eva NYC
- Cornell Capital investments in Instant Brands
- Maidenform acquisition by Hanesbrands
- VF acquisition of Timberland
Defense
- Lockheed Martin acquisition of Sikorsky Aircraft
Joint Ventures and Other Arrangements
- Comcast investments in Clearwire, along with Google, Intel, and Time Warner Cable
- Atairos in the combination of Learfield and IMG College
- Comcast commercial agreements with Verizon Wireless
- Warner Chilcott global collaboration agreement with Sanofi-Aventis
Insights
Credentials
Recognition
Chambers USA – Corporate/M&A, New York
Chambers USA – Private Equity: Buyouts, New York
IFLR1000 – M&A, United States
Law360 – “Rising Star: M&A,” 2014, 2016
Chambers USA – “Up and Coming Individual,” 2016
Education
- magna cum laude
Professional history
- Partner, 2011-present
- Davis Polk since 2002
Qualifications and admissions
- State of New York